Cook Medical's Zilver® PTX® Earns FDA Approval As First ... | 合法醫療器材資訊網

2012年11月15日—ZilverPTXismadeofnitinol,a“shapememory”metalalloy,andisengineeredtowithstandthedynamicforcesofthesuperficialfemoralartery( ...

Bloomington, Ind. — Cook Medical has received U.S. Food and Drug Administration (FDA) marketing approval for the first devices in its Zilver® PTX® Drug-Eluting Peripheral Stent portfolio, company officials reported today. It’s the first time the FDA has approved a drug-eluting stent to treat blockages in a peripheral artery.

“This approval marks the start of Cook’s program to bring the benefits of drug elution to U.S. physicians treating the peripheral arteries,” said Rob Lyles, vice president and global leader of Cook Medical’s Peripheral Intervention division.“No other company can match Cook’s commitment to this technology, and by the end of 2013, we expect to have a full suite of drug-eluting peripheral stents in the most commonly used lengths and diameters available to U.S. physicians.”

“This approval marks the start of Cook’s program to bring the ...